E7386

Phase 1Completed
2 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Food Effect in Healthy Participants

Conditions

Food Effect in Healthy Participants

Trial Timeline

Jun 7, 2019 → Oct 29, 2019

About E7386

E7386 is a phase 1 stage product being developed by Eisai for Food Effect in Healthy Participants. The current trial status is completed. This product is registered under clinical trial identifier NCT03996226. Target conditions include Food Effect in Healthy Participants.

What happened to similar drugs?

2 of 3 similar drugs in Food Effect in Healthy Participants were approved

Approved (2) Terminated (1) Active (0)
OmalizumabNovartisApproved
Omalizumab InjectionRocheApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (4)

NCT IDPhaseStatus
NCT04840927Phase 1Withdrawn
NCT03996226Phase 1Completed
NCT03833700Phase 1Active
NCT03264664Phase 1Active